History Timeline
Over the years, EORTC’s clinical research has helped make significant progress in the treatment and management of cancer, evaluating new molecules, refining existing treatment regimens, identifying biomarkers and assessing patients’ quality of life.
Many of our 1600+ studies in the past 60 years have resulted in practice-changing treatments and the establishment of new standards of care, or shown that others are ineffective or redundant.
-
Georges Mathé (President: 1962 -1965)
Villejuif - France
1962
Founded as an international organisation under Belgian law as Groupe Européen de Chimiothérapie Anticancéreuse (GECA)
-
Silvio Garattini (President: 1965-1968)
Milan - Italy
1965
Launched European Journal of Cancer, an international multidisciplinary oncology journal, together with the European CanCer Organisation (ECCO), the European Association for Cancer Research (EACR) and the European Society of Breast Cancer Specialists (EUSOMA)
-
Silvio Garattini (President: 1965-1968)
Milan - Italy
1968
Changed its name to European Organisation for Research and Treatment of Cancer (EORTC)
-
D. Willem van Bekkum (President: 1969-1975)
Rijswijk - Netherlands
-
D. Willem van Bekkum (President: 1969-1975)
Rijswijk - Netherlands
1972
Opened the NCI liaison office within the EORTC premises
-
D. Willem van Bekkum (President: 1969-1975)
Rijswijk - Netherlands
1974
Established the EORTC Data Center (today EORTC headquarters) to provide methodological and coordinating services by clinical research specialists to EORTC groups
-
Henri Tagnon (President: 1975-1978)
Brussels - Belgium
-
Henri Tagnon (President: 1975-1978)
Brussels - Belgium
1976
Created EORTC Foundation (today EORTC Cancer Research Fund)
-
Lazlo George Latja (President: 1979-1981)
Manchester - United Kingdom
-
Carl Gottfried Schmidt (President: 1981-1984)
Essen - Germany
-
Umberto Veronesi (President: 1985-1988)
Milan - Italy
-
Louis Denis (President: 1988-1991)
Antwerp - Belgium
-
Emmanuel Van der Schueren (President: 1991-1994)
Leuven - Belgium
1991
Prof. Françoise Meunier appointed Director at the EORTC Headquarter
-
Royal decree under Belgium law allowing EORTC Fellowship Programme
-
Emmanuel Van der Schueren (President: 1991-1994)
Leuven - Belgium
1993
Created the Quality of Life department at EORTC, and introduction of EORTC QLQ-C30, the first validated general cancer Quality of Life questionnaire for cancer patients. In our experience, measurement system is now the most frequently-used QoL questionnaire in cancer clinical trials worldwide
-
Gordon McVie (President: 1994-1997)
London - United Kingdom
-
Gordon McVie (President: 1994-1997)
London - United Kingdom
1995
Prof Françoise Meunier appointed first EORTC Director General
-
Gordon McVie (President: 1994-1997)
London - United Kingdom
1996
Created the Regulatory department
-
Jean-Claude Horiot (President: 1997-2000)
Genolier - Switzerland
1997
Created the EORTC Pharmacovigilance department
-
Allan T. van Oosterom (President: 2000-2003)
Leuven - Belgium
-
Alexander M. Eggermont (President: 2003-2006)
Villejuif - France
-
Alexander M. Eggermont (President: 2003-2006)
Villejuif - France
2005
Created the EORTC Academic fund to support non-commercial pivotal clinical trials
-
Martine Piccart (President: 2006-2009)
Brussels - Belgium
-
Martine Piccart (President: 2006-2009)
Brussels - Belgium
2007
Established of the EORTC Network of Core Institutions
-
Martine Piccart (President: 2006-2009)
Brussels - Belgium
2008
Introduced EORTC Radiotherapy Quality Assurance
-
Jean-Yves Blay (President: 2009-2012)
Lyon - France
2009
Created EORTC Imaging Platform
-
Jean-Yves Blay (President: 2009-2012)
Lyon - France
2010
Developed specific methodology for clinical trials in the elderly
-
Jean-Yves Blay (President: 2009-2012)
Lyon - France
2012
- Strategy shift led to new cross-discipline programmes such as SPECTA for translational research and Survivorship for outcomes research
- In partnership with Alliance Boots, launched SPECTAcolor programme for research in advanced colorectal cancer
-
Roger Stupp (President: 2012-2017)
Chicago - United States
2014
- Held first EORTC Cancer Survivorship Summit
- Selected to join EU Expert Group on Cancer Control
-
Roger Stupp (President: 2012-2017)
Chicago - United States
2015
Prof Denis Lacombe appointed Director General of the EORTC Headquarters and Prof. Françoise Meunier as Director Special Projects
-
Roger Stupp (President: 2012-2017)
Chicago - United States
2016
- Established central biobanking system to support precision medicine clinical research
- Entered a landmark collaborative agreement with the Japan Clinical Oncology Group
-
Bertrand Tombal (Past President: 2017-2021)
Brussels - Belgium
-
Winette van der Graaf (President: 2022-current)
Amsterdam - Netherlands